Chlorambucil is a cytotoxic chemotherapy drug, prescribed for chronic lymphocytic leukemia, non-Hodgkin's lymphoma, Hodgkin's disease and lymphosarcoma. The risk or severity of adverse effects can be ...

Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group Database A total of 100 ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved the use of intravenous ofatumumab in combination with chlorambucil for patients with ...

Please provide your email address to receive an email when new articles are posted on . Patients with chronic lymphocytic leukemia treated with chlorambucil and rituximab experienced better outcomes ...

Results of the CLL14 trial, which were presented today at the 2019 Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois, resulted in the approval of the venetoclax ...

Across treatment classes, CH associated with increased therapy-related cytopenias, particularly neutropenia, and DNMT3A/TET2 ...

Review the side-effects of Chlorambucil as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Early and Late Therapy Response Assessment With [18F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial Patients (≤ 75 years ...

Patients with relapsed CLL which is refractory to chlorambucil and fludarabine should be offered combination chemotherapy [e.g. low-dose cyclophosphamide, prednisolone, vincristine and doxorubicin ...

The FDA approval of the first-line indication is based on results from a Phase III study (COMPLEMENT 1) which demonstrated statistically significant improvement in median progression-free survival ...

You have full access to this article via your institution. All subjects completed treatment, but two had significant dosing delays, one due to a mechanical ileus unrelated to therapy requiring ...

Chronic lymphocytic leukaemia (CLL) is a malignancy of mature B lymphocytes which occurs in older adults. A 'wait and watch' approach is taken with patients with early-stage CLL. Treatment of ...